PMC7772029_01
Yellowish-gray blurred mass that extended into the vitreous.
CRIOPM2020-8861435.001.jpg
PMC7772029_01_CRIOPM2020-8861435.001.jpg
fig1
Four days following the injection, plus disease and ROP stage were regressed in the left eye but retinal imaging demonstrated a yellowish-gray blurred mass that extended into the vitreous in the right eye, and the vitreous body was blurred (Figure 1).
Favorable anatomic result was achieved four weeks after the pars plana vitrectomy.
CRIOPM2020-8861435.002.jpg
PMC7772029_01_CRIOPM2020-8861435.002.jpg
fig2
A favorable and satisfactory anatomic result was achieved four weeks after the surgery (Figure 2).